Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Common Equity (2016 - 2025)

Neuronetics (STIM) has disclosed Common Equity for 10 consecutive years, with $31.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Common Equity rose 234.29% to $31.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $31.4 million, a 234.29% increase, with the full-year FY2024 number at $31.8 million, down 6.99% from a year prior.
  • Common Equity was $31.4 million for Q3 2025 at Neuronetics, roughly flat from $31.5 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $102.0 million in Q1 2021 to a low of $9.4 million in Q3 2024.
  • A 5-year average of $52.5 million and a median of $45.5 million in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: crashed 75.27% in 2024, then soared 234.29% in 2025.
  • Neuronetics' Common Equity stood at $85.2 million in 2021, then tumbled by 33.01% to $57.1 million in 2022, then crashed by 40.08% to $34.2 million in 2023, then dropped by 6.99% to $31.8 million in 2024, then decreased by 1.38% to $31.4 million in 2025.
  • Per Business Quant, the three most recent readings for STIM's Common Equity are $31.4 million (Q3 2025), $31.5 million (Q2 2025), and $39.5 million (Q1 2025).